Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07559318 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Post-Emergency Optimization of Antibiotic Therapy for Urinary Tract Infection (UTI)

Study acronym: REVIU48
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv4
  2. Recruitment opened
    • Trial sites expanded: 0 → 3 locations
    v3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Prospective, multicenter, non-interventional study conducted over 6 months, including patients presenting to the emergency department with suspected urinary tract infection managed as outpatients and discharged with or without empiric antibiotic therapy. Discharge antibiotic prescriptions are reviewed, with subsequent reassessment and optimization of treatment based on urine culture and susceptibility results
Trial Details
NCT Number NCT07559318
Lead Sponsor Centre Hospitalier Intercommunal Creteil
Conditions
(from sponsor)		 Urinary Tract Infections, Antiobiotic Stewardship, Emerging Infectious Disease
Related terms Communicable Diseases, Emerging, Urinary Tract Infections
Enrollment 330 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov